Rivernorth Capital Management’s Eucrates Biomedical Acquisition Corp. Unit EUCRU Stock Holding History

Rivernorth Capital Management’s Portfolio EUCRU Stock Details EUCRU Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell
2022 Q3	$758K	Hold
2022 Q2	$759K	Hold
2022 Q1	$747K	Buy
2021 Q1	–	Sell
2020 Q4	$1.07M	Buy